Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Prognostic impact of minimal residual disease on...
Conference

Prognostic impact of minimal residual disease on outcome in the SORMAIN trial

Authors

Burchert A; Bug G; Finke J; Stelljes M; Roellig C; Wollmer E; Waesch R; Bornhaeuser M; Berg T; Lang F

Volume

42

Pagination

pp. 16-16

Publisher

KARGER

Publication Date

2019

Conference proceedings

ONCOLOGY RESEARCH AND TREATMENT

ISSN

2296-5270